Disc Medicine to Participate in SVB Securities Global Biopharma Conference

Rhea-AI Summary

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company, announced that CEO John Quisel will participate in a fireside chat at the SVB Securities Global Biopharma Conference on February 16, 2023, at 8:40 a.m. ET. The event will be held virtually, and a live webcast can be accessed via the investor relations section of the company's website. Disc Medicine focuses on developing novel treatments for serious hematologic diseases, targeting key biological pathways, including heme biosynthesis and iron homeostasis. For further details, visit the company's website.

WATERTOWN, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that John Quisel, J.D., Ph.D., Chief Executive Officer and President of Disc Medicine, will participate in a fireside chat in a virtual format at the SVB Securities Global Biopharma Conference on Thursday, February 16, 2023 at 8:40 a.m. ET.

A live webcast of the fireside chat will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available.

About Disc Medicine

Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Verge Scientific Communications
prusconi@vergescientific.com

Investor Relations Contact

Suzanne Messere
Stern Investor Relations
suzanne.messere@sternir.com

FAQ

What is the date and time of the Disc Medicine fireside chat at the SVB Securities Global Biopharma Conference?

The fireside chat is scheduled for February 16, 2023, at 8:40 a.m. ET.

Who is participating in the fireside chat for Disc Medicine?

John Quisel, J.D., Ph.D., the CEO and President of Disc Medicine, will participate.

Where can I watch the Disc Medicine fireside chat?

You can watch the fireside chat through the investor relations section of Disc Medicine's website.

What is the focus of Disc Medicine's treatments?

Disc Medicine focuses on novel treatments for serious hematologic diseases, particularly in heme biosynthesis and iron homeostasis.

What stock symbol represents Disc Medicine?

Disc Medicine is represented by the stock symbol IRON.